My problem with your take is his negativity keeps driving the SP down. Most of us have thought of every single negative aspect he mentions but are smart enough to know not to broadcast them because we know a small stock can gain a buzz and investors start to take notice and financial media starts to take notice and buzz about Leronlimab can be the result. It would only take the eye of one tight person to change the game.